Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Angiotensin receptor autoantibodies as biomarker for effected usage of angiotensin receptor blockers

Angiotensin receptor autoantibodies as biomarker for effected usage of angiotensin receptor blockers

US Patent 10648977 · Granted May 12, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Protective, anti-inflammatory receptor and its use in preservation of mitochondr2020
Protective, anti-inflammatory receptor and its use in preservation of mitochondr2020
Supramolecular hydrogels containing angiotensin receptor blockers for targeted t2020
Supramolecular hydrogels containing angiotensin receptor blockers for targeted t2020
Selective targeting of an anti-inflammatory receptor in human mitochondria and p2020
Selective targeting of an anti-inflammatory receptor in human mitochondria and p2020
Complex formed by N-linked glycoproteins (SIBLINGS)and Factor H2006
Polypeptide for obesity and type II diabetes mellitus1999
Susceptibility gene for obesity and type II diabetes mellitus1998